Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.
Description: All cause mortality at Day 60
Measure: Mortality at Day 60 Time: 60 days post treatmentDescription: Dialysis Dependency at Day 60
Measure: Dialysis Dependency Time: 60 days post treatmentDescription: Ventilation free survival at Day 28
Measure: Ventilation at Day 28 Time: 28 days post treatmentDescription: Dialysis Dependency at Day 28
Measure: Dialysis Dependency Time: 28 days post treatmentDescription: All cause mortality at Day 28
Measure: Mortality at Day 28 Time: 28 days post treatmentDescription: Change from baseline in urine output
Measure: Urinary output change Time: 10 days of treatmentDescription: Change from baseline in PO2/FiO2
Measure: P02/FiO2 change Time: 10 days of treatmentDescription: Assessment of SAEs, AE and UADEs
Measure: Safety Assessments Time: 10 days of treatmentDescription: Assessment of device performance
Measure: SCD Integrity Time: 10 days of treatmentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports